Kao Corporation 4452.JP
Kao is Japan's underperforming FMCG giant; adding five expert directors with FMCG, cosmetics and digital expertise plus performance-aligned pay can close the peer gap and revive growth.
Thesis
Kao Corp is Japan's largest FMCG company with iconic brands like Curel, Biore, Sensai and Molton Brown, yet under President Hasebe it has posted negative real consumer-goods growth 2020-24, the lowest ROIC among global peers (8.3% versus L'Oreal/P&G at 17-19%), and a 60-point shareholder-return gap to the Nikkei. Oasis blames a board lacking FMCG supply-chain, marketing, finance and digital expertise, compounded by R&D overspend, marketing underspend and a 'Another Kao' diversification distraction into healthcare and enzyme batteries. The deck proposes five additive independent directors (Skoufalos from P&G, Velando from Aesop, Venator from KFC/Estee Lauder, Dineen from J&J, Lagodny from JT) alongside long-term incentives tied to organic sales, gross margin and ROIC. The pitch is explicitly constructive: incumbents stay, board expands from 8 to 14, matching peer scale.
SCQA
Kao Corp (4452.JP) is Japan's largest FMCG company, founded 1890, with JPY 3.04tn market cap, JPY 1.63tn FY24 revenue, brands like Biore, Curel and Sensai, plus a sizable oleochemicals business.
Under President Hasebe, Kao posted negative real consumer-goods growth 2020-24, ROIC of 8.3% versus 14%+ peers, Health & Beauty operating margins at -7.5%, and trailed the Nikkei by 60 points, driven by R&D overspend, marketing underspend, and a board lacking FMCG expertise.
Vote FOR shareholder proposals #4-7 at the 2025 AGM: elect five additive independent directors with FMCG supply chain, cosmetics, marketing, digital and turnaround expertise, and approve compensation reforms tying executive pay to organic sales, gross margin and ROIC.
Closing the peer gap on growth, margin and capital efficiency would re-rate Kao toward Beiersdorf and L'Oreal multiples; no explicit target price is given, but peers delivered ~37-38% TSR over 2021-Feb 2025 versus Kao's -9%.
The three reasons
- 1
Kao is the only global FMCG with negative real consumer-goods CAGR 2020-24 (-0.2% vs L'Oreal +10.7%)
- 2
Kao's ROIC has collapsed to 8.3%, far below peers (P&G 19%, L'Oreal 17%) and below its own pre-Covid 14% baseline
- 3
Board lacks FMCG supply chain, marketing, finance and digital expertise; five additive directors close the peer skills gap
Primary demands
- Elect five additive independent directors at the 2025 AGM (Skoufalos, Velando, Venator, Dineen, Lagodny) without removing incumbents
- Approve executive equity compensation reform (Item #5) tied to organic sales, gross margin and credible ROIC targets
- Approve non-executive equity compensation (Item #6) granting outside directors 1,000 shares annually
- Approve compensation limit adjustments (Item #7) to accommodate the expanded board
- Refocus management on core consumer goods (FMCG) rather than 'Another Kao' diversification into healthcare and enzyme batteries
- Reduce R&D overspend and reallocate to marketing and brand investment
KPIs cited
Pattern membership
Where this document fits across the library's 12 rhetorical / structural patterns.
Precedents cited
- Fujitec (Oasis prior engagement)
- Tokyo Dome (Oasis prior engagement)
- Sun Corp (Oasis prior engagement)
- Raysum (Oasis prior engagement)
Notable slides (6)
Notes
Standout craft features: bespoke 'A Better Kao' campaign brand identity (logo, color system, dedicated abetterkao.com microsite), consistent header treatment with the underline-accent and the headline-as-verdict device ('LOW', 'UNDERPERFORM', 'LAGGING', 'DECLINING', 'FAILING', 'OVERSPENDING', 'UNDER-INVESTING', 'BELOW'). Strong peer-gap charts on every operating metric (ROIC, gross margin, marketing spend, R&D, TSR). Heavy use of CEO-quote contradictions to expose strategic drift ('Another Kao' slide on p.28 is the rhetorical centerpiece). Stake percentage not disclosed in the document. Posture is unusually constructive for a proxy fight — explicitly framed as 'additive, not either/or' (incumbents remain, board expands 8 to 14). The deck has a recurring chevron-style table-of-contents 'progress bar' marking each section transition (a navigation device worth swiping). Investor-survey quotes are used as third-party validation throughout. No SOTP / no formal target price — argument is qualitative re-rating via governance fix.